| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 17.47▲ | 17.71▼ | 17.81▼ | 17.14▲ | 14.20▲ |
| MA10 | 17.56▼ | 17.81▼ | 17.81▼ | 15.66▲ | 12.43▲ |
| MA20 | 17.67▼ | 17.80▼ | 17.33▲ | 14.62▲ | 9.35▲ |
| MA50 | 17.79▼ | 17.57▼ | 16.47▲ | 12.07▲ | 8.02▲ |
| MA100 | 17.70▼ | 16.30▲ | 15.30▲ | 9.01▲ | 9.16▲ |
| MA200 | 17.57▼ | 15.21▲ | 13.68▲ | 7.64▲ | 280.32▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.017▼ | -0.068▼ | -0.064▼ | 0.251▲ | 0.960▲ |
| RSI | 43.710▼ | 48.113▼ | 52.203▲ | 67.227▲ | 77.271▲ |
| STOCH | 20.717 | 35.776 | 41.791 | 70.208 | 83.267▲ |
| WILL %R | -61.458 | -79.444▼ | -45.732 | -30.757 | -14.470▲ |
| CCI | -13.949 | -159.296▼ | -44.912 | 110.504▲ | 188.018▲ |
|
Wednesday, October 08, 2025 09:05 AM
Premarket trading on Wednesday showed a generally upbeat tone, reflecting a modest rebound after the previous day’s declines. On the New York Stock Exchange (NYSE), about 65% of listed stocks (1,190) ...
|
|
Wednesday, August 27, 2025 12:00 AM
WAYNE, Pa., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company fully dedicated to developing IL-1β-based treatments for immune-mediated ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/10/25 | 17.75 | 18.215 | 17.315 | 17.50 | 507,889 |
| 23/10/25 | 17.02 | 19.20 | 16.535 | 17.92 | 513,175 |
| 22/10/25 | 17.06 | 17.77 | 15.58 | 15.78 | 523,781 |
| 21/10/25 | 17.52 | 19.41 | 17.10 | 17.43 | 912,406 |
| 20/10/25 | 15.95 | 17.50 | 15.36 | 17.075 | 727,246 |
| 17/10/25 | 13.93 | 15.49 | 13.60 | 15.35 | 364,321 |
| 16/10/25 | 14.15 | 15.00 | 13.90 | 14.00 | 249,681 |
| 15/10/25 | 13.99 | 14.2753 | 13.42 | 13.90 | 187,261 |
| 14/10/25 | 13.59 | 14.235 | 13.365 | 13.99 | 169,313 |
| 13/10/25 | 13.79 | 14.48 | 13.20 | 13.67 | 273,970 |
|
|
||||
|
|
||||
|
|